Espregnol to Expand Global Offline Channels via Partnerships with Medical and Pharmacy Networks

South Korea, 17th Oct 2025 – Pre-conception (pregnancy-prep) wellness formula Espregnol announced that, following a nationwide sell-out of its 5th production run in the Republic of Korea, it has begun manufacturing the 6th batch with a renewed premium formula. In line with this, the company stated it is preparing to expand global offline distribution by building partnerships with local OB/GYN clinics and pharmacy networks.

According to the company, surging interest in EsPregnol has been accompanied by growing demand for women’s circulation & balance management (Balanced Vital Sync. Flow), leading to increased inquiries from potential overseas partners. 

While maintaining multi-language labeling and allergen disclosures compliant with each country’s regulations, as well as bottle-level batch QR traceability (showing summaries of key quality tests such as heavy metals and microbiological counts), EsPregnol is discussing the co-distribution of a standardized counseling sheet for physicians and pharmacists at pharmacy counters (including full ingredient lists and recommended 2–3-hour co-administration intervals).

At the initial stage, the roadmap under review includes pilot listings with pharmacy chains, tests in airport/drugstore channels, and integration with a 24/7 international Adverse Event Reporting (AER) system, to be rolled out sequentially.

An EsPregnol spokesperson said, “Having sold out our 5th run domestically and commenced premium-renewal 6th production, we will pursue both stable supply and standardized offline counseling. Through collaborations with medical and pharmacy networks, we are preparing information delivery and distribution aligned with each country’s standards.”

Company Details

Organization: Onim

Contact Person: Oh, Raegwon

Website: https://from-in-labs.com/

Email: Send Email

Country: Korea South

Release Id: 17102535542